Britt Jeppson Day, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14757 Nw County Road 12, Bristol, FL 32321 Phone: 850-643-2426 |
Hammadah Talib Wahlquist Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11288 Nw State Road 20, Bristol, FL 32321 Phone: 850-570-7178 |
Mrs. Jordan Sims Wahlquist, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11899 Nw Lake Mystic Duggar Rd, Bristol, FL 32321 Phone: 850-643-2088 |
Communication Station & Consulting, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10659 Nw State Road 20, Bristol, FL 32321 Phone: 850-643-1979 Fax: 850-643-1293 |
News Archive
Everyone knows children are getting fatter and that both a poor diet and a lack of exercise are to blame. But, what researchers have been unable to discover until now, is exactly how major a role activity plays in the battle to keep obesity at bay.
Longer toes and a unique ankle structure provide sprinters with the burst of acceleration that separates them from other runners, according to biomechanists.
A recent theory suggesting that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was doing the rounds in California as early as November 2019, infecting thousands undetected and leading to herd immunity, was debunked by experts from the scientific community. Antibody testing by a group of Stanford Medicine researchers was linked to the theory.
BistroMD, the leader in home diet meal delivery, announced a licensing partnership today with Fitness Icon Denise Austin to create a branded meal-delivery program. The program is a natural extension of bistroMD's mission to empower people to lose weight while eating great tasting, nutritious foods, and blends with Denise's healthy lifestyle philosophy.
Biotage AB a global leader in tools and technology for medicinal and analytical chemistry, and the owners of MIP Technologies AB today announced that the parties have signed a definitive agreement under which Biotage will acquire all outstanding shares in MIP Technologies, a privately held leading developer of molecularly imprinted polymers (MIPs) and other novel polymers.
› Verified 8 days ago